Plus Intangibles To Total Assets from 2010 to 2024

PSTV Stock  USD 1.31  0.04  2.96%   
Plus Therapeutics Intangibles To Total Assets yearly trend continues to be fairly stable with very little volatility. Intangibles To Total Assets will likely drop to 0.03 in 2024. Intangibles To Total Assets is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. View All Fundamentals
 
Intangibles To Total Assets  
First Reported
2010-12-31
Previous Quarter
0.03635406
Current Value
0.0345
Quarterly Volatility
0.1474998
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Plus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Plus Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 375.2 K, Selling General Administrative of 10.2 M or Selling And Marketing Expenses of 637 K, as well as many indicators such as Price To Sales Ratio of 1.06, Dividend Yield of 0.0022 or Days Sales Outstanding of 46.47. Plus financial statements analysis is a perfect complement when working with Plus Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Plus Therapeutics Correlation against competitors.
For more information on how to buy Plus Stock please use our How to Invest in Plus Therapeutics guide.

Latest Plus Therapeutics' Intangibles To Total Assets Growth Pattern

Below is the plot of the Intangibles To Total Assets of Plus Therapeutics over the last few years. It is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. Plus Therapeutics' Intangibles To Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Plus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Intangibles To Total Assets10 Years Trend
Slightly volatile
   Intangibles To Total Assets   
       Timeline  

Plus Intangibles To Total Assets Regression Statistics

Arithmetic Mean0.15
Geometric Mean0.08
Coefficient Of Variation98.85
Mean Deviation0.13
Median0.08
Standard Deviation0.15
Sample Variance0.02
Range0.3419
R-Value(0.51)
Mean Square Error0.02
R-Squared0.26
Significance0.05
Slope(0.02)
Total Sum of Squares0.30

Plus Intangibles To Total Assets History

2024 0.0345
2023 0.0364
2022 0.0195
2021 0.0192
2020 0.0378
2019 0.016
2018 0.0155

About Plus Therapeutics Financial Statements

Plus Therapeutics investors use historical fundamental indicators, such as Plus Therapeutics' Intangibles To Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Plus Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Intangibles To Total Assets 0.04  0.03 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Plus Stock Analysis

When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.